Abstract:
Currently available data have a major impact on widening the applications area of zinc
oxide (ZnO) and gallium nitride (GaN) nanoparticles (NPs). Being a new medical domain,
nanomedicine shows a spectacular growth of published works. Thus, in this paper we
aimed to provide comprehensive current information on the implementation of inoffensive
synthetized ZnO and GaN nanoparticles. The articles in the PubMed database, Bethesda
(MD): US National Library of Medicine, „PubMed.gov”, Google Scholar Academic
containing the keywords "nanoparticles, zinc oxide, gallium nitride, cytotoxicity,
adhesion" were selected. From these articles it was collected and processed the
information related to the applicability of ZnO and GaN NPs. Nanoparticles based on ZnO
and GaN currently have a wide range of implementation in the field of oncology,
antibacterial, antifungal domains. The combination of ZnO and GaN nanoparticles as
adjuvants in target factor treatments shows an increased efficacy of the active substance
obtained by ecological methods. The application of ZnO GaN NPs requires innovative
methods to obtain beneficial results in biomedicine. Possession of clinical nomenclature
for use of ZnO and GaN NPs would reduce their cytotoxic effects in practical
applications.